The Straussman lab studies mechanisms of resistance to anti-cancer therapies. Tumors are heterogeneous and are made of highly complex ecosystems. Accordingly, our studies reach beyond the tumor cells to include the multiple components of the tumor microenvironment, including the tumor microbiome. We use cutting edge technologies to study mechanisms that modulate the response to cytotoxic, targeted and immune-mediated anti-cancer therapies. We strive to develop better treatment options for cancer patients. We develop drugs in the space of cancer immunology and anti-cancer vaccines.
2022 The Youdim Family Prize for Excellence in Cancer Research
2019 ERC Consolidator grant
2014 Neufeld Memorial research prize
2014 Rising tide foundation new investigator award.
2014 Incumbent of the Roel C. Buck Career Development Chair
2012 AACR scholar-in-training award
2006 Philip Morris External Research Program Postdoctoral Fellowship
2005 The Anonymous Fund UK with Dr. Nemeth Post-Doctoral fellowship
1999 The Foulkes foundation fellowship
1997 Dean List
1996 Dean Prize
1995 Rector Prize